Brain-computer interfaces
An implant reads cortical activity and turns it into words. This is no longer a laboratory demonstration: someone uses it every day, at home. It is still a handful of patients worldwide.
A brain-computer interface does something that until recently belonged to the imagination: it listens to the electrical activity of a group of neurons and converts it into an action outside the body. Moving a cursor. Typing. Speaking.
It is worth being precise from the outset about what is being read, because everything else depends on that precision. These systems do not read thoughts. They read the motor intention to articulate: the command the precentral cortex sends to the muscles of the mouth, tongue and larynx when someone tries to speak, even when those muscles no longer respond. The command still leaves. What fails is the path. The interface does not interpret mental content: it intercepts a motor instruction that has lost its recipient.
What happened
In 2023 the field changed scale. Two teams published in the same issue of Nature the decoding of speech in near real time: one using electrodes that penetrate a few millimetres into the cortex1, the other using a sheet of contacts resting on the brain surface, able to generate text, synthesised voice and the animation of a face at once2. The following year, work in the New England Journal of Medicine showed that such a system could begin working twenty-five days after surgery, with an accuracy that until then had required months of training3. In 2025 came the hardest advance of all: instantaneous voice synthesis, with millisecond latency, which gives the user back the ability to hear themselves as they speak — and therefore to modulate tone, to interrupt, to improvise a word the system had never seen4.
The figure that matters most to us, however, is none of the speed records. It is a 2026 paper in Nature Medicine: a man with amyotrophic lateral sclerosis using his interface independently, at home, for nearly nineteen months. More than three thousand eight hundred hours. Close to two million words. And something many had assumed was lost in advance: more than ninety per cent of the electrodes were still recording activity at the end of that period, with no decline in performance5.
In parallel, another line restores movement rather than speech. A "digital bridge" between the motor cortex and the spinal cord below the injury allowed a man with a ten-year-old cervical lesion to stand and walk again in real-world settings6. And in a more modest, more everyday register, there are patients controlling virtual fingers and external devices with a fluency that did not exist a few years ago7.
Where this actually stands
This is where the voice should drop.
Each of those results comes from one patient. Not a cohort, not a comparative trial: a single participant, at a handful of centres worldwide. There is still no randomised study, no control group, no population-level evidence. What does exist, and is solid, is surgical safety data: fourteen people implanted over seventeen years, with more than twelve thousand accumulated device-days, without a single intracranial infection or forced explant8. The fragile point turned out not to be the brain but the skin around the connector that exits the skull.
There is also a route that avoids craniotomy entirely: an electrode carried inside a vein until it rests against the cortex. It is safe and it does not migrate9, but it delivers an order of magnitude less than an intracortical implant. Choosing between approaches is not a matter of technical elegance: it is an explicit trade between invasiveness and bandwidth.
And as of August 2026 there is no chronically implanted brain-computer interface with marketing authorisation. Everything that exists is an early feasibility study. This deserves to be said plainly, because regulatory vocabulary invites confusion: a breakthrough device designation is an accelerated review pathway, not an approval, and the agency itself states that such a device must still demonstrate safety and effectiveness before it can be marketed10. The only concrete authorisation in this area covers a surface electrode for temporary use of under thirty days — useful, real, and something rather different from a permanent implant11.
What falls to us
There is a point of identity that tends to be overlooked: every one of these devices reaches the brain through the hands of a neurosurgeon. Public discussion concentrates on the algorithms, and the algorithms are extraordinary; but between the intention and the word there is a craniotomy, a plane of dissection, a dura that opens and closes, and a decision about exactly where to lay a sheet of electrodes. Software does not solve that.
One question remains, one this field raised and that is not going away. In November 2025 UNESCO adopted the first global standard on the ethics of neurotechnology, establishing mental privacy as a condition of human dignity, requiring prior, free and informed consent for the collection of neural data, and expressly advising against its use in the workplace12. That current technical capability is still far from the scenario that debate imagines does not make the debate premature. It makes it prudent to begin now, while beginning is still possible.